{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "currency": "EUR", "market": "dr_market", "esgPopulated": false, "gmtOffSetMilliseconds": 7200000, "exchange": "FRA", "longName": "Molecular Templates, Inc.", "shortName": "MOLECULAR TEMPLAT.DL-,001", "regularMarketPrice": 0.365, "regularMarketChangePercent": -0.5449602, "messageBoardId": "finmb_27892633", "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.68975776, "fiftyTwoWeekLow": 0.2576, "fiftyTwoWeekHigh": 1.1765, "earningsTimestamp": 1680214225, "earningsTimestampStart": 1683923400, "earningsTimestampEnd": 1684182600, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "fiftyTwoWeekLowChange": 0.1074, "fiftyTwoWeekLowChangePercent": 0.41692546, "fiftyTwoWeekRange": "0.2576 - 1.1765", "fiftyTwoWeekHighChange": -0.81149995, "epsTrailingTwelveMonths": -1.65, "epsForward": -1.77, "epsCurrentYear": -1.54, "priceEpsCurrentYear": -0.237013, "sharesOutstanding": 56351600, "bookValue": -0.269, "fiftyDayAverage": 0.366434, "fiftyDayAverageChange": -0.0014339983, "fiftyDayAverageChangePercent": -0.0039133877, "twoHundredDayAverage": 0.532476, "twoHundredDayAverageChange": -0.167476, "twoHundredDayAverageChangePercent": -0.3145231, "marketCap": 20579576, "forwardPE": -0.2062147, "priceToBook": -1.3568774, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.7 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1198825200000, "priceHint": 4, "regularMarketChange": -0.002000004, "regularMarketTime": 1683871252, "regularMarketDayHigh": 0.365, "regularMarketDayRange": "0.365 - 0.365", "regularMarketDayLow": 0.365, "regularMarketVolume": 1000, "regularMarketPreviousClose": 0.367, "bid": 0.3685, "ask": 0.4215, "bidSize": 0, "askSize": 0, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 0.365, "averageDailyVolume3Month": 1547, "averageDailyVolume10Day": 100, "symbol": "NZW2.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "9301 Amberglen Boulevard", "address2": "Suite 100", "city": "Austin", "state": "TX", "zip": "78729", "country": "United States", "phone": "512 869 1555", "website": "https://www.mtem.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company primarily develops therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT- 8421, an ETB candidate that is in Phase I clinical trial for the treatment of dismantling TME through direct cell-kill of tumor and immune cell; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory multiple myeloma; and MT-6402 in that is in Phase I clinical trial for relapsed/refractory patients with PD-L1 expressing tumors. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.", "fullTimeEmployees": 111, "companyOfficers": [{"maxAge": 1, "name": "Dr. Eric E. Poma Ph.D.", "age": 50, "title": "CEO, Chief Scientific Officer & Director", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 923340, "fmt": "923.34k", "longFmt": "923,340"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jason S Kim", "age": 47, "title": "Pres, COO, Interim CFO, Treasurer and Principal Financial & Accounting Officer", "yearBorn": 1975, "fiscalYear": 2022, "totalPay": {"raw": 639846, "fmt": "639.85k", "longFmt": "639,846"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Roger J. Waltzman M.B.A., M.D.", "age": 54, "title": "Chief Medical Officer", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 639720, "fmt": "639.72k", "longFmt": "639,720"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Megan C. Filoon", "title": "Gen. Counsel & Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Michael  Dowd", "title": "Sr. VP of Project & Alliance Management", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ryan  Hawkins", "title": "Sr. VP & Head of Manufacturing", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Joseph  Phillips Ph.D.", "title": "Sr. VP & Head of CMC Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Kristen  Quigley B.A.", "age": 51, "title": "Sr. VP of Clinical Operations", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 10, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 5, "overallRisk": 7, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}